Return to Trial Database

TBCRC035

Palbociclib in Combination with Fulvestrant or Tamoxifen as Treatment for Hormone Receptor Positive Metastatic Breast Cancer with Prior Chemotherapy for Advanced Disease: A Phase II study with Pharmacodynamics Markers (TBCRC035)

Status

Study Completed

Cancer Type(s)

Study Contact

Trial Locations

All sites in which the trial TBCRC035 being conducted in.

No data was found